Active Clinical Studies for Hematologic/Blood Cancers

Comprehensive Cancer Centers runs research studies for hematologic/blood cancers cancers:

A Phase 4, Observational Study Evaluating the Efficacy and Safety of the Bruton Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Patients With Waldenström Macroglobulinemia.
Study #: i3141
Contact Us: For information about this clinical study, Email Us.

A Phase 3, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy and Safety of Elritercept (KER-050) for the Treatment of Transfusion- Dependent Anemia in Adult Participants with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) (RENEW)
Study #: Independent
Contact Us: For information about this clinical study, Email Us.

Leukemia Studies

A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia (POLARIS-2).
Study #: i3332
Contact Us: For information about this clinical study, Email Us.